CymaBay Therapeutics Inc. (CBAY) Stock Rating Upgraded by HC Wainwright - Sports Perspectives

Market Digest
CymaBay Therapeutics Inc. (CBAY) Stock Rating Upgraded by HC Wainwright
Sports Perspectives
CymaBay Therapeutics logo CymaBay Therapeutics Inc. (NASDAQ:CBAY) was upgraded by research analysts at HC Wainwright from a “neutral” rating to a “buy” rating in a research report issued on Monday. The brokerage currently has a $6.00 price ...
CymaBay Therapeutics Inc. (CBAY) Upgraded by HC Wainwright to BuyThe Cerbat Gem
H.C. Wainwright Just Issued " Buy" Ratin